Aimmune Therapeutics: 1Q Earnings Snapshot
Aimmune Therapeutics: 1Q Earnings Snapshot
BRISBANE, Calif. (AP) _ Aimmune Therapeutics Inc. (AIMT) on Wednesday reported a loss of $54.3 million in its first quarter.
On a per-share basis, the Brisbane, California-based company said it had a loss of 87 cents.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 94 cents per share.
Aimmune Therapeutics shares have dropped 16% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $20.04, a fall of 35% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AIMT at https://www.zacks.com/ap/AIMT